Skip to main content
. 2021 Nov 22;2021(11):CD004407. doi: 10.1002/14651858.CD004407.pub5

ca‐Snijders 2012.

Study characteristics
Methods Retrospective cohort ‐ vaccine effectiveness in primary cases and in households
Participants Children attending primary schools and their household contacts. Schools were eligible when they had at least 1 laboratory‐confirmed mumps case or more than 1 clinical mumps case.
Interventions MMR vaccine. Parents of schoolchildren were asked to fill out a questionnaire asking for information on the child's vaccination status (since 2007). To define the vaccination status, the study authors used individual information registered in the national Dutch vaccination register (‘Praeventis’). Information on vaccination status for 69 pupils (6%) could not be obtained from this register (66 no informed consent, 3 unknown vaccination status in register). For these children, authors used the self‐reported vaccination status (vaccinated/not vaccinated), assuming for vaccinated children that 1 dose was received when the child was aged < 8.75 years, and 2 doses when the child was aged ≥ 8.75 years.
Outcomes Mumps cases were defined by affirmative answer (by parental report) to the question "has your child had mumps after September 2007?".
Funding Source Government
Notes The vaccine effectiveness was based on the clinical disease of mumps only. VE is provided adjusted for possible confounders.
Risk of bias
Bias Authors' judgement Support for judgement
PCS/RCS ‐ exposed cohort selection Unclear risk National register or self‐reported
PCS/RCS ‐ non‐exposed cohort selection Unclear risk National register or self‐reported
PCS/RCS ‐ comparability Unclear risk There was insufficient information.
PCS/RCS ‐ assessment of outcome Unclear risk By questionnaire
Summary Risk of Bias assessment Unclear risk We had concerns regarding at least 1 domain such that some doubt is raised about the results.